Medtronic grants PSUs and options to EVP Kiil
Medtronic plc EVP & President Cardiovascular Harry Skip Kiil received several equity awards.
Rhea-AI Filing Summary
Medtronic plc EVP & President Cardiovascular Harry Skip Kiil received several equity awards. On August 3, 2026 he was granted 23,074 performance share units that may result in between 0 and 55,378 shares depending on three-year performance measured through April 27, 2029, 65,556 stock options with an $86.68 exercise price expiring in 2036, and 9,230 restricted stock units that vest fully on the third anniversary of grant.
On July 31, 2026, 3,074 ordinary shares were withheld at $85.39 per share to satisfy tax obligations upon the vesting of previously granted restricted stock units.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
KIIL HARRY SKIP
Role
EVP & President Cardiovascular
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Share Units F4, F5, F6 | 23,074 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F7 | 65,556 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F3 | 9,230 | $0.00 | $0.00 |
| Tax Withholding | Ordinary Shares F1, F2 | 3,074 | $85.39 | $262K |
Holdings After Transaction:
Performance Share Units — 23,074 contracts (Direct);
Stock Option (Right to Buy) — 65,556 contracts (Direct);
Ordinary Shares — 43,669 shares (Direct)
Footnotes (7)
- F1. Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
- F2. Includes 286 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- F3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- F4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- F5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
- F6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 23,074 shares will be issued. If maximum performance metrics are achieved, 55,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Key Figures
Performance share units granted: 23,074 units
Maximum PSU payout shares: 55,378 shares
Stock options granted: 65,556 options
+5 more
8 metrics
Performance share units granted
23,074 units
Grant to EVP & President Cardiovascular on August 3, 2026 tied to Medtronic common stock
Maximum PSU payout shares
55,378 shares
Shares issued if maximum performance metrics are achieved over a three-year performance period
Stock options granted
65,556 options
Right to buy Medtronic ordinary shares granted on August 3, 2026
Option exercise price
$86.68 per share
Exercise price for 65,556 stock options expiring on August 3, 2036
Restricted stock units granted
9,230 units
Restricted stock units vest 100% on the third anniversary of the grant date
Shares withheld for taxes
3,074 shares
Ordinary shares withheld at $85.39 per share on July 31, 2026 to satisfy tax on RSU vesting
Tax withholding share price
$85.39 per share
Price per share for 3,074 ordinary shares withheld for tax obligations
Dividend reinvestment shares
286 shares
Additional shares acquired through dividend reinvestment since the last report
Key Terms
Performance share units, restricted stock units, dividend reinvestment, exercisable
4 terms
restricted stock units financial
"Represents restricted stock units that vest 100% on the third anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"Includes 286 shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
exercisable financial
"These options become exercisable at the rate of 25% of the shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Medtronic (MDT) EVP Harry Skip Kiil receive on August 3, 2026?
On August 3, 2026, Harry Skip Kiil received 23,074 performance share units, 65,556 stock options at $86.68 per share, and 9,230 restricted stock units. These awards provide future rights to Medtronic ordinary shares subject to vesting and performance conditions.
What are the terms of Harry Skip Kiil’s Medtronic (MDT) stock options?
Harry Skip Kiil was granted 65,556 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options become exercisable at 25% of the shares per year, starting on the first anniversary of the grant date.
When do Harry Skip Kiil’s 9,230 Medtronic (MDT) restricted stock units vest?
Harry Skip Kiil’s grant of 9,230 restricted stock units vests 100% on the third anniversary of the August 3, 2026 grant date. Once vested, each restricted stock unit represents one Medtronic ordinary share, assuming all vesting conditions are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
